Blue Water Life Science Advisors as of March 31, 2022
Portfolio Holdings for Blue Water Life Science Advisors
Blue Water Life Science Advisors holds 10 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera (NTRA) | 21.8 | $46M | 1.1M | 40.68 | |
| Guardant Health (GH) | 20.8 | $44M | 661k | 66.24 | |
| Caredx (CDNA) | 18.0 | $38M | 1.0M | 36.99 | |
| Pacific Biosciences of California (PACB) | 11.5 | $24M | 2.7M | 9.10 | |
| Akoya Biosciences (AKYA) | 10.9 | $23M | 2.1M | 10.99 | |
| 10x Genomics Cl A Com (TXG) | 7.7 | $16M | 212k | 76.07 | |
| Somalogic Class A Com | 3.8 | $8.0M | 992k | 8.02 | |
| Ginkgo Bioworks Holdings Cl A Shs (DNA) | 3.4 | $7.2M | 1.8M | 4.03 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 1.8 | $3.7M | 210k | 17.66 | |
| Pear Therapeutics Class A Com (PEARQ) | 0.5 | $983k | 195k | 5.05 |
